Harvard Medical School Executive Education Webinar: Patient-Centric Drug Development for Rare Diseases

Where

Virtual

When

{{getUserDateTimeZone("1648569600").singleDate}}
{{getUserDateTimeZone("1648569600").time}} - {{getUserDateTimeZone("1648572300").time}} {{getClientTimeZoneName()}}

About

In this webinar, Ethan Perlstein, PhD will discuss how highly motivated and entrepreneurial rare genetic disease families are increasingly becoming drug developers. Dr. Perlstein will illustrate this thesis with the Maggie’s Pearl story.

Host

More events in "Biotech"

{{getUserDateTimeZone("1683115200").day}} {{getUserDateTimeZone("1683115200").month}} In-person 2023 Breakthrough Summit

STAT heads to the west coast to explore the innovations changing health care as we know it. Unlock two full days of conversation exploring w…

Alondra Nelson and Rick Berke on the STAT Summit stage.

{{getUserDateTimeZone("1693933200").day}} {{getUserDateTimeZone("1693933200").month}} Virtual 2023 STAT Future Summit

The biggest names in health and science, all in one (virtual) place. Sign up to receive an alert when we launch tickets – STAT+ subscr…

{{getUserDateTimeZone("1697630400").day}} {{getUserDateTimeZone("1697630400").month}} Boston, MA 2023 STAT Summit

Come for two days of silo-breaking and solution-focused discussions on the most important topics in health care with some of the industry&#8